The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Breast cancer screening for carriers of ATM, CHEK2, and PALB2 pathogenic variants: A comparative modeling analysis.
 
Kathryn P. Lowry
Research Funding - GE Healthcare (Inst)
 
H. Amarens Geuzinge
No Relationships to Disclose
 
Natasha K. Stout
No Relationships to Disclose
 
Oguzhan Alagoz
No Relationships to Disclose
 
John M. Hampton
No Relationships to Disclose
 
Karla Kerlikowske
(OPTIONAL) Uncompensated Relationships - GRAIL
 
Diana L. Miglioretti
No Relationships to Disclose
 
Clyde Schecter
No Relationships to Disclose
 
Brian L. Sprague
No Relationships to Disclose
 
Amy Trentham-Dietz
No Relationships to Disclose
 
Anna N.A. Tosteson
No Relationships to Disclose
 
Nicolien Van Ravesteyn
No Relationships to Disclose
 
Martin Yaffe
Stock and Other Ownership Interests - Conavi Medical; Harmonic Medical; Innovexe; Medical Physics Incorporated; Moleculite; Volpara Health Technologies
Research Funding - BHR Pharma; GE Healthcare (Inst); GE Healthcare (Inst)
 
Jennifer Yeh
No Relationships to Disclose
 
Fergus Couch
Consulting or Advisory Role - AstraZeneca
Speakers' Bureau - Ambry Genetics; Qiagen
Research Funding - GRAIL
Travel, Accommodations, Expenses - GRAIL; Qiagen
Other Relationship - Ambry Genetics
 
Peter Kraft
No Relationships to Disclose
 
Eric Polley
Research Funding - GRAIL
 
Jeanne S. Mandelblatt
No Relationships to Disclose
 
Allison W. Kurian
Research Funding - Myriad Genetics (Inst)
Other Relationship - Ambry Genetics; Color Genomics; GeneDx/BioReference; Genentech; InVitae
 
Mark E. Robson
Consulting or Advisory Role - Change HealthCare
Research Funding - AstraZeneca (Inst); Merck (Inst); Pfizer (Inst)
Other Relationship - Clinical Care Options; Invitae (Inst); Pfizer; Physicans' Education Resource; Research to Practice
(OPTIONAL) Uncompensated Relationships - Daiichi Sankyo; Epic Sciences; Merck; Pfizer